Alzamend Neuro annual total assets
2020
2021
2022
2023
2024
2025
2026
Alzamend Neuro Total Assets Growth & History (ALZN)
Alzamend Neuro's total assets was $2.1M for fiscal 2026.
View full Alzamend Neuro company overviewAlzamend Neuro annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-04-30 | $2.1M | −$2.5M | −54.83% |
| 2025 | 2025-04-30 | $4.6M | $4.0M | +628.80% |
| 2024 | 2024-04-30 | $631,588 | −$5.3M | −89.32% |
| 2023 | 2023-04-30 | $5.9M | −$8.6M | −59.25% |
| 2022 | 2022-04-30 | $14.5M | $11.6M | +398.40% |
| 2021 | 2021-04-30 | $2.9M | $1.1M | +60.56% |
| 2020 | 2020-04-30 | $1.8M | — | — |
Alzamend Neuro quarterly total assets
Q4.20
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-04-30 | $2.1M | −$2.5M | −54.83% |
| Q3 2026 | 2026-01-31 | $4.0M | −$133,801 | −3.20% |
| Q2 2026 | 2025-10-31 | $5.1M | $83,966 | +1.68% |
| Q1 2026 | 2025-07-31 | $6.3M | $4.7M | +278.88% |
| Q4 2025 | 2025-04-30 | $4.6M | $4.0M | +628.80% |
| Q3 2025 | 2025-01-31 | $4.2M | $3.4M | +433.53% |
| Q2 2025 | 2024-10-31 | $5.0M | $4.0M | +409.12% |
| Q1 2025 | 2024-07-31 | $1.7M | −$958,153 | −36.46% |
| Q4 2024 | 2024-04-30 | $631,588 | −$5.3M | −89.32% |
| Q3 2024 | 2024-01-31 | $782,636 | −$7.7M | −90.79% |
| Q2 2024 | 2023-10-31 | $983,597 | −$9.4M | −90.56% |
| Q1 2024 | 2023-07-31 | $2.6M | −$9.6M | −78.48% |
| Q4 2023 | 2023-04-30 | $5.9M | −$8.6M | −59.25% |
| Q3 2023 | 2023-01-31 | $8.5M | −$3.9M | −31.60% |
| Q2 2023 | 2022-10-31 | $10.4M | −$4.1M | −28.11% |
| Q1 2023 | 2022-07-31 | $12.2M | −$4.6M | −27.39% |
| Q4 2022 | 2022-04-30 | $14.5M | $11.6M | +398.40% |
| Q3 2022 | 2022-01-31 | $12.4M | — | — |
| Q2 2022 | 2021-10-31 | $14.5M | — | — |
| Q1 2022 | 2021-07-31 | $16.8M | — | — |
| Q4 2021 | 2021-04-30 | $2.9M | $1.1M | +60.56% |
| Q4 2020 | 2020-04-30 | $1.8M | — | — |
Alzamend Neuro total assets trends
Over the last five fiscal years, Alzamend Neuro's total assets decreased from $2.9M to $2.1M, a change of −$833,227. The latest reported quarter, Q4 2026, shows $2.1M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Alzamend Neuro source filings ↗